Using a novel MAP kinase phosphatase-2 mutant to differentially regulate vascular smooth muscle cell proliferation and endothelial cell apoptosis

Plevin, Robin (Principal Investigator)

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Project: Research

Project Details

Description

Using a novel MAP kinase phosphatase-2 mutant to differentially regulate vascular smooth muscle cell proliferation and endothelial cell apoptosis

Status	Finished
Effective start/end date	1/04/12 → 31/03/14

Funding

British Heart Foundation BHF: £112,862.00